Concourse Financial Group Securities, Inc. Genocea Biosciences, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

13 transactions

Quarter	Operation	Price Per share	shares change
Q2 2022 Aug 09, 2022	SELL	$0.01 - $1.38 $0 - $0	0 Closed
Q1 2022 May 09, 2022	BUY	$0.96 - $1.35 $0 - $0	0 New
Q4 2021 Feb 07, 2022	BUY	$0.95 - $1.99 $0 - $0	0 New
Q3 2021 Nov 09, 2021	BUY	$1.74 - $2.33 $0 - $0	0 New
Q2 2021 Aug 13, 2021	BUY	$2.06 - $2.82 $0 - $0	0 New
Q1 2021 May 13, 2021	BUY	$2.35 - $4.01 $0 - $0	0 New
Q4 2020 Feb 02, 2021	BUY	$1.91 - $2.67 $0 - $0	0 New
Q3 2020 Nov 13, 2020	BUY	$1.81 - $5.53 $0 - $0	0 New
Q2 2020 Aug 13, 2020	BUY	$1.66 - $3.06 $0 - $0	0 New
Q1 2020 May 13, 2020	BUY	$1.26 - $2.73 $0 - $0	0 New
Q4 2019 Feb 14, 2020	BUY	$2.05 - $2.82 $0 - $0	0 New
Q3 2019 Nov 13, 2019	BUY	$2.9 - $4.07 $0 - $0	0 New
Q2 2019 Aug 13, 2019	BUY	$3.47 - $6.71 $0 - $0	0 New

Others Institutions Holding GNCA

# of Institutions

Shares Held

10K

Call Options Held

Put Options Held

Madison Park Capital Advisors, LLC Seattle, WA

10K
Shares

$0
0.0% of portfolio

View Full List

About GENOCEA BIOSCIENCES, INC.

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

More about GNCA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account